Navigation

Appraisals in development

This table lists NICE technology appraisals. The list can be sorted by title (alphabetically), wave number, anticipated publication date and process. You can also click the appraisal title for full details, or click a column heading to sort the list by that column.

Appraisals in development

Results 121-140 of 149

Title Anticipated publication date Referral date Process
Prostate cancer (metastatic, hormone-relapsed) - enzalutamide [ID683] May 2015 Feb 2014 STA
Prostate cancer (metastatic, hormone relapsed) - sipuleucel-T (1st line) [ID573] Feb 2015 STA
Prostate cancer (prevention) - dutasteride [ID75] TBC Mar 2009 STA
Prostate cancer - intensity modulated radiotherapy [ID17] TBC Mar 2008 MTA
Psoriasis (plaque, moderate to severe) - secukinumab [ID718] Jul 2015 Feb 2014 STA
Psoriasis - briakinumab (suspended) [ID65] TBC Nov 2008 STA
Psoriatic arthritis (active) - ustekinumab [ID607] May 2014 STA
Psoriatic arthritis (moderate to severe) - leflunomide [ID391] TBC Nov 2005 STA
Pulmonary arterial hypertension (adults) - drugs [ID12] TBC Apr 2005 MTA
Renal cell carcinoma (advanced) - axitinib [ID518] Jun 2014 Feb 2012 STA
Renal cell carcinoma (second line metastatic) - pazopanib [ID70] Jan 2011 Nov 2008 STA
Renal transplantation (adults) - immunosuppressive therapy (including Review of TA 85) [ID456] Sep 2014 MTA
Renal transplantation (children, adolescents) - immunosuppressive regimens (review of TA99) [ID346] TBC MTA
Rheumatoid arthritis (after the failure of conventional DMARDs) -rituximab [ID333] TBC Apr 2010 STA
Rheumatoid arthritis - adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, abatacept and tocilizumab - review [ID537] TBC MTA
Rheumatoid arthritis - adalimumab, etanercept and infliximab (sequential use) [ID18] TBC Jun 2004 MTA
Rheumatoid arthritis - tofacitinib [ID526] TBC May 2012 STA
Soft tissue or bone sarcoma (metastatic) - ridaforolimus (maintenance) [ID415] TBC Sep 2011 STA
Systemic lupus erythematosus (autoantibody-positive) - belimumab [ID416] TBC Nov 2010 STA
Systemic lupus erythematosus - prasterone [ID392] TBC Oct 2000 MTA

This page was last updated: 22 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.